BRD7 Antikörper (C-Term)

Produktnummer ABIN927760

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch BRD7 in WB. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für BRD7 Antikörper (C-Term) (ABIN927760)

Target: BRD7 (Bromodomain Containing 7 (BRD7))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser BRD7 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-BRD7 Antikörper

Bindungsspezifität: C-Term

Aufreinigung: Purified

Immunogen: BRD7 antibody was raised in rabbit using the C terminal of BRD7 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

BRD7 Blocking Peptide, (ABIN939729), is also available for use as a blocking control in assays to test for specificity of this BRD7 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu BRD7

Target: BRD7 (Bromodomain Containing 7 (BRD7))

Andere Bezeichnung: BRD7

Hintergrund: BRD7 is an activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. It induces dephosphorylation of GSK3B at 'Tyr-216'. Synonyms: Polyclonal BRD7 antibody, Anti-BRD7 antibody, bromodomain containing 7 antibody, BP75 antibody, CELTIX1 antibody, NAG4 antibody.